{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:19:34Z","timestamp":1787635174792,"version":"build-2736575974"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"DOI":"10.1007\/s00428-026-04692-y","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T04:46:44Z","timestamp":1787633204000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Basal crypt dysplasia in inflammatory bowel disease: morphological quandaries, p53 immunohistochemistry and diagnostic pointers"],"prefix":"10.1007","author":[{"given":"Kristen M.","family":"Stashek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2124-515X","authenticated-orcid":false,"given":"Runjan","family":"Chetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"4692_CR1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1136\/jcp-2023-209141","volume":"77","author":"Z Alipour","year":"2024","unstructured":"Alipour Z, Stashek K (2024) Recently described types of dysplasia associated with IBD: tips and clues for the practising pathologist. J Clin Pathol 77:77\u201381","journal-title":"J Clin Pathol"},{"key":"4692_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.humpath.2023.05.008","volume":"138","author":"N Harpaz","year":"2023","unstructured":"Harpaz N, Goldblum JR, Shepherd NA et al (2023) Colorectal dysplasia in chronic inflammatory bowel disease: a contemporary consensus classification and interobserver study. Hum Pathol 138:49\u201361","journal-title":"Hum Pathol"},{"key":"4692_CR3","doi-asserted-by":"publisher","unstructured":"Harpaz N, Odze RD Updated pathologic classification of inflammatory bowel disease-associatedcolorectal dysplasia: a guide for clinicians. Inflam Bowel Dis 2026:izag011.https:\/\/doi.org\/10.1093\/ibd\/izag011","DOI":"10.1093\/ibd\/izag011"},{"key":"4692_CR4","unstructured":"Choi W-T, Odze RD, Polydorides AD et al Inflammatory bowel disease Associated dysplasia of the colorectum. In: WHO Classification of Tumours Editorial Board. Digestive system tumours [Internet]. Lyon (France): International Agency for Research on Cancer; 2026 [cited 2026 06 24]. (WHO classification of tumours series, 6th ed.; vol. 1). Available from: https:\/\/tumourclassification.iarc.who.int\/chapters\/72"},{"key":"4692_CR5","doi-asserted-by":"publisher","first-page":"105959","DOI":"10.1016\/j.humpath.2025.105959","volume":"169","author":"D Bahceci","year":"2025","unstructured":"Bahceci D, Choi W-T (2025) Recent updates and debates on basal crypt dysplasia, serrated epithelial change, and p53 immunostaining in inflammatory bowel disease. Hum Pathol 169:105959. https:\/\/doi.org\/10.1016\/j.humpath.2025.105959","journal-title":"Hum Pathol"},{"key":"4692_CR6","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/his.13923","volume":"75","author":"KW Wen","year":"2019","unstructured":"Wen KW, Umetsu SE, Goldblum JR, Gill RM, Kim GE, Joseph NM et al (2019) DNA flow cytometric and interobserver study of crypt cell atypia in inflammatory bowel disease. Histopathology 75:578\u2013588","journal-title":"Histopathology"},{"key":"4692_CR7","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1093\/ecco-jcc\/jjab120","volume":"16","author":"WT Choi","year":"2022","unstructured":"Choi WT, Salomao M, Zhao L, Alpert L, Setia N, Liao X et al (2022) Hypermucinous, goblet cell deficient, and crypt cell dysplasias in inflammatory bowel disease are often associated with flat\/invisible endoscopic appearance and advanced neoplasia on follow-up. J Crohns Colitis 16:98\u2013108","journal-title":"J Crohns Colitis"},{"key":"4692_CR8","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.dld.2016.12.011","volume":"49","author":"D Saraggi","year":"2017","unstructured":"Saraggi D, Fassan M, Mescoli C et al (2017) The molecular landscape of colitis-associated carcinogenesis. Dig Liver Dis 49:326\u2013330","journal-title":"Dig Liver Dis"},{"issue":"5","key":"4692_CR9","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1046\/j.1365-2559.2001.01274.x","volume":"39","author":"AE Noffsinger","year":"2001","unstructured":"Noffsinger AE, Belli JM, Miller MA, Fenoglio-Preiser CM (2001) A unique basal pattern of p53 expression in ulcerative colitis is associated with mutation in the p53 gene. Histopathology 39(5):482\u2013492","journal-title":"Histopathology"},{"key":"4692_CR10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1136\/jcp-2023-209206","volume":"78","author":"C Lang-Schwarz","year":"2025","unstructured":"Lang-Schwarz C, B\u00fcttner-Herold M, Burian S et al (2025) Morphological subtypes of colorectal low-grade intraepithelial neoplasia: diagnostic reproducibility, frequency and clinical impact. J Clin Pathol 78:103\u2013110","journal-title":"J Clin Pathol"},{"key":"4692_CR11","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1093\/ecco-jcc\/jjac090","volume":"16","author":"R Zhang","year":"2022","unstructured":"Zhang R, Lauwers GY, Choi WT (2022) Increased risk of non-conventional and invisible dysplasias in patients with primary sclerosing cholangitis and inflammatory bowel disease. J Crohns Colitis 16:1825\u20131834","journal-title":"J Crohns Colitis"},{"key":"4692_CR12","doi-asserted-by":"publisher","unstructured":"Urquhart SA, Pallipamu N, Voruganti HV et al (2025) Nonconventional dysplasia in patients with inflammatory bowel disease and colorectal adenocarcinoma: a case cohort study. J Crohns Colitis 19(2). https:\/\/doi.org\/10.1093\/eccojcc\/jjaf022","DOI":"10.1093\/eccojcc\/jjaf022"},{"issue":"3","key":"4692_CR13","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1053\/j.gastro.2021.10.035","volume":"162","author":"SC Shah","year":"2022","unstructured":"Shah SC, Itzkowitz SH (2022) Colorectal cancer in inflammatory bowel disease: mechanisms and management. Gastroenterology 162(3):715\u2013730","journal-title":"Gastroenterology"},{"issue":"3","key":"4692_CR14","doi-asserted-by":"publisher","first-page":"gutjnl2025","DOI":"10.1136\/gutjnl-2025-335023","volume":"75","author":"JE East","year":"2025","unstructured":"East JE, Gordon M, Nigam GB et al (2025) British Society of Gastroenterology Guidelines on colorectal surveillance in inflammatory bowel disease. Gut 75(3):gutjnl2025\u2013335023. https:\/\/doi.org\/10.1136\/gutjnl-2025-335023","journal-title":"Gut"},{"key":"4692_CR15","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1093\/gastro\/gov022","volume":"3","author":"B Horvath","year":"2015","unstructured":"Horvath B, Liu G, Wu X et al (2015) Overexpression of p53 predicts colorectal neoplasia risk in patients with inflammatory bowel disease and mucosa changes indefinite for dysplasia. Gastroenterol Rep 3:344\u2013349","journal-title":"Gastroenterol Rep"},{"key":"4692_CR16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ajg.2016.06.003","volume":"17","author":"EB Brahim","year":"2016","unstructured":"Brahim EB, Mrabet A, Jouini R et al (2016) Immunohistochemistry in the diagnosis of dysplasia in chronic inflammatory bowel disease colorectal polyps. Arab J Gastroenterol 17:121\u2013126","journal-title":"Arab J Gastroenterol"},{"key":"4692_CR17","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/his.14848","volume":"82","author":"KJ Tomaszewski","year":"2023","unstructured":"Tomaszewski KJ, Neyaz A, Sauder K et al (2023) Defining an abnormal p53 immunohistochemical stain in Barrett\u2019s oesophagus-related dysplasia: a single-positive crypt is a sensitive and specific marker of dysplasia. Histopathology 82:555\u2013566","journal-title":"Histopathology"},{"key":"4692_CR18","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1053\/j.gastro.2021.10.038","volume":"162","author":"M Redston","year":"2022","unstructured":"Redston M, Noffsinger A, Kim A et al (2022) Abnormal TP53 predicts risk of progression in patients with Barrett\u2019s esophagus regardless of a diagnosis of dysplasia. Gastroenterology 162:468\u2013481","journal-title":"Gastroenterology"},{"key":"4692_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/his.70199","author":"JD Louie","year":"2026","unstructured":"Louie JD, Lauwers GY, Choi W-T (2026) Aberrant p53 overexpression in benign colon biopsies may predict dysplasia risk in patients with primary sclerosing cholangitis and inflammatory bowel disease. Histopathology. https:\/\/doi.org\/10.1111\/his.70199","journal-title":"Histopathology"},{"key":"4692_CR20","doi-asserted-by":"publisher","first-page":"100419","DOI":"10.1016\/j.modpat.2023.100419","volume":"37","author":"N Nasreddin","year":"2024","unstructured":"Nasreddin N, Jansen M, Loughrey MB et al (2024) Poor diagnostic reproducibility in the identification of nonconventional dysplasia in colitis impacts the application of histologic stratification tools. Mod Pathol 37:100419","journal-title":"Mod Pathol"},{"key":"4692_CR21","doi-asserted-by":"publisher","first-page":"104179","DOI":"10.1016\/j.labinv.2025.104179","volume":"105","author":"M Ramineni","year":"2025","unstructured":"Ramineni M, Ettel M, Hao Y, Liao X (2025) SATB2 loss is a sensitive biomarker for dysplasia in inflammatory bowel disease. Lab Invest 105:104179","journal-title":"Lab Invest"},{"key":"4692_CR22","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/his.15243","volume":"85","author":"S Okano","year":"2024","unstructured":"Okano S, Fukata M, Murakami T et al (2024) Ki-67 distribution, \u03b1-methylacyl CoA racemase (AMACR) expression and mucin phenotypes are associated with non-polypoid growth in ulcerative colitis-associated neoplasia. Histopathology 85:671\u2013685","journal-title":"Histopathology"},{"key":"4692_CR23","doi-asserted-by":"crossref","unstructured":"Liang Y, Hao Y, Xiong Y, et al. MYC overexpression in inflammatory bowel disease-associated conventional dysplasia and association of subsequent low grade dysplasia in follow-up biopsies. Pathol Res Pract 2023;248:154642","DOI":"10.1016\/j.prp.2023.154642"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04692-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-026-04692-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04692-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T04:46:55Z","timestamp":1787633215000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-026-04692-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":23,"alternative-id":["4692"],"URL":"https:\/\/doi.org\/10.1007\/s00428-026-04692-y","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"assertion":[{"value":"15 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This is a review article and did not involve any patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}